Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.810
+0.080 (+4.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
Next >
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
August 14, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 12, 2024
Via
ACCESSWIRE
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
July 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 05, 2024
Via
ACCESSWIRE
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies News Update
May 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 24, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
March 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
February 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies In The News
January 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
January 23, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies In the News
January 08, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
January 05, 2024
Via
ACCESSWIRE
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 30, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
November 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
November 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 06, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
October 10, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
September 19, 2023
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
September 07, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.